XML 76 R64.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-Based Compensation (Narrative) (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 24, 2024
USD ($)
milestone
Oct. 04, 2022
USD ($)
shares
Dec. 01, 2021
USD ($)
milestone
Feb. 29, 2024
USD ($)
milestone
Mar. 31, 2024
USD ($)
milestone
$ / shares
shares
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         3 years    
Stock-based compensation expense         $ 8,252,000 $ 10,292,000  
Unrecognized stock-based compensation expense         $ 34,001,000    
Unrecognized stock-based compensation expense, period for recognize         1 year 9 months 18 days    
Share-Based Payment Arrangement, Tranche One              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage         33.33%    
Share-Based Payment Arrangement, Tranche Two              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage         33.33%    
Share-Based Payment Arrangement, Tranche Three              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentage         33.33%    
Phantom Share Units (PSUs) | Systemic Bio Phantom Unit Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares) | shares         88,000    
Stock-based compensation expense         $ 67,000 0  
Incentive Awards              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense         $ 1,594,000 658,000  
Performance Shares              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of non-financial milestones | milestone         4    
Restricted Stock Units (RSUs)              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period         3 years    
Granted (in shares) | shares         60,000    
Granted (in dollars per share) | $ / shares         $ 5.75    
Volumetric Biotechnologies, Inc.              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense         $ 0 2,267,000  
Additional payments     $ 355,000,000 $ 355,000,000      
Number of milestones | milestone     7        
Milestones terminated | milestone 4     4 4    
Remaining milestones | milestone 3     3 3    
Business combination, contingent consideration, reduced liability $ 175,000,000     $ 175,000,000      
Earnout payment milestone           65,000,000  
Aggregate grant date fair value of outstanding and unvested           4,679,000  
Deferred compensation             $ 0
Volumetric Biotechnologies, Inc. | Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of milestones | milestone       4      
Volumetric Biotechnologies, Inc. | Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of milestones | milestone       7      
Dp polar GmbH              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense         $ 243,000 $ 274,000  
Additional payments   $ 2,229,000          
Issuance of shares (in shares) | shares   250,000